Calithera Biosciences, Inc. (NASDAQ:CALA) has scheduled a conference call for 10th August 2020 at 5:00 PM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.calithera.com
Earnings Expectation
Calithera Biosciences, Inc. is set to announce second quarter earning results on Monday 10th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CALA to report 2Q20 loss of $ 0.33 per share. For the full year, analysts anticipate loss of $ 1.39 per share bottom line.
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. Its lead product candidate is CB-839, an inhibitor of glutaminase, which is in Phase II clinical trial to treat solid tumors. The company also offers INCB001158, an oral inhibitor of arginase that is in Phase I/II clinical trial for the treatment of hematology and oncology.
